Hematology NewsOlder age predicts mortality after alloHCT in NHL, but not relapseOctober 24, 2018Aggressive LymphomasCellular TherapyLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology NewsStudy challenges LVEF assessment before DLBCL treatmentOctober 19, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsIbrutinib discontinuation harms survival in CLLOctober 18, 2018CLLMantle Cell LymphomaIndolent LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsEntospletinib falls short in relapsed/refractory DLBCLOctober 11, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology NewsMCL treatment choices depend partly on ageOctober 10, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesPhase 1 NHL, ALL trials placed on clinical holdOctober 10, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Oncology PracticeALTA-1L: Brigatinib beats crizotinib for PFS in ALK-positive NSCLCOctober 9, 2018Lung CancerB Cell Lymphoma
Hematology TimesWeighing the costs of CAR T-cell therapyOctober 7, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLAggressive LymphomasB Cell Lymphoma
Hematology TimesCAR T therapy being explored in Hodgkin lymphomaOctober 6, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesDuvelisib bests ofatumumab as monotherapy for treatment of CLL/SLLOctober 5, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology Times5-year remission rates with combo prove durable in MCLOctober 4, 2018Lymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology NewsNovel options for treating hairy cell leukemiaOctober 2, 2018CLLLeukemia, Myelodysplasia, TransplantationIndolent LymphomaB Cell Lymphoma
Hematology TimesGround-breaking therapy comes with distinct challengesOctober 2, 2018Lymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology TimesTwo immunologists receive Nobel Prize in medicineOctober 1, 2018Lymphoma & Plasma Cell DisordersRelated IssuesHodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsFDA lifts partial hold on tazemetostat trialsSeptember 30, 2018T Cell LymphomasLymphoma & Plasma Cell DisordersAggressive LymphomasFollicular LymphomaB Cell LymphomaSarcoma & GIST
